Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In children with bacterial meningitis, age and presenting neurologic status are the most important predictors of hearing loss, and neither dexamethasone nor glycerol…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – In children with attention deficit hyperactivity disorder (ADHD), adding divalproex to stimulant therapy can improve refractory aggression, a small study suggests. “Stimulant medications…
NEW YORK (Reuters Health) – Core needle biopsies seem almost as accurate as open biopsy in detecting breast cancer, and less prone to complications, a meta-analysis has found.…
NEW YORK (Reuters Health) – The Prove-it sepsis assay (Mobidiag, Helsinki, Finland) is highly sensitive and specific in identifying bacterial species in blood samples and provides much faster…
NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…
NEW YORK (Reuters Health) – High-flow inhaled oxygen is an effective treatment for cluster headache attacks, investigators said in the Journal of the American Medical Association for December…
NEW YORK (Reuters Health) – Children who are disease-free 5 years after a cancer diagnosis are still at risk for recurrence for another 20 years or more, new…
NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA),…
NEW YORK (Reuters Health) – Methadone is a safe, effective first- or second-line treatment of cancer pain, even in outpatients, a retrospective study suggests. Concerns over its long…
